ArticlePloS one2025

Ultrasounic-radiomics models for predicting the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma.

Yiran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.